Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published online before print January 30, 2008, doi:10.1212/01.wnl.0000286941.74372.cc)
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
01.wnl.0000286941.74372.ccv1
70/19_Part_2/1771    most recent
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schultz, M. R.
Right arrow Articles by Kremen, W. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schultz, M. R.
Right arrow Articles by Kremen, W. S.
NEUROLOGY 2008;70:1771-1777
© 2008 American Academy of Neurology

Apolipoprotein E genotype and memory in the sixth decade of life

M. R. Schultz, MA, M. J. Lyons, PhD, C. E. Franz, PhD, M. D. Grant, PhD, C. Boake, PhD, K. C. Jacobson, PhD, H. Xian, PhD, G. D. Schellenberg, PhD, S. A. Eisen, MD, MSc and W. S. Kremen, PhD

From the Department of Psychology (M.R.S., M.J.L., M.D.G.), Boston University, MA; Department of Psychiatry (C.E.F., W.S.K.) and Center for Behavioral Genomics (W.S.K.), University of California, San Diego; The Institute for Rehabilitation and Research (C.B.), Houston, TX; Department of Psychiatry (K.C.J.), University of Chicago, IL; Research Service (H.X., S.A.E.) and Medical Service (S.A.E.), St. Louis VA Medical Center, MO; Departments of Internal Medicine (H.X., S.A.E.) and Psychiatry (S.A.E.), Washington University School of Medicine, St. Louis, MO; VA Puget Sound Healthcare System (G.D.S.); and Division of Gerontology and Geriatric Medicine (G.D.S.), Department of Medicine, and Departments of Neurology and Pharmacology (G.D.S.), University of Washington, Seattle.

Address correspondence and reprint requests to Dr. William S. Kremen, Department of Psychiatry, Center for Behavioral Genomics, University of California, San Diego, 9500 Gilman Drive (MC 0738), La Jolla, CA 92093-0738 wkremen{at}ucsd.edu

Background: Virtually all adult studies of APOE genotypes and cognition have included individuals over 60. In older adults, {varepsilon}4 carriers may manifest greater cognitive asymmetries than non-{varepsilon}4 carriers even in the absence of overall mean differences. General cognitive ability may also be affected by aging and APOE genotype, but most studies have inadequately addressed this potential confound. The goals of this study were to examine, in middle age, the relationship of APOE genotype with episodic memory and verbal-visuospatial episodic memory asymmetries, after accounting for prior general cognitive ability.

Method: We compared {varepsilon}4+ and {varepsilon}4– individuals in 626 male twins in their 50s. We examined verbal and visuospatial episodic memory and verbal-visual asymmetry scores after adjusting for cognitive ability at age 20. Analyses corrected for correlations between twin pair members.

Results: Compared with {varepsilon}4– individuals, {varepsilon}4 carriers performed significantly more poorly on verbal, but not visuospatial memory, manifested significantly greater cognitive asymmetry, and also had significantly more concerns about memory. At age 20, {varepsilon}4 carriers had higher general cognitive ability than {varepsilon}4– individuals, and current memory differences were enhanced after adjusting for age 20 cognitive ability.

Conclusions: Small, but significant, APOE-{varepsilon}4-related memory deficits appear in the sixth decade of life in individuals who show no signs of preclinical dementia. The results partially support studies of older adults that suggest that increased cognitive asymmetries reflect risk for dementia and are associated with the APOE-{varepsilon}4 genotype. The results also highlight the potential problems of not having accurate data on prior cognitive ability.

Abbreviations: AD = Alzheimer disease; AFQT = Armed Forces Qualification Test; CES-D = Center for Epidemiologic Studies Depression Scale; VETSA = Vietnam Era Twin Study of Aging; WMS-III = Wechsler Memory Scale.


e-Pub ahead of print on January 30, 2008, at www.neurology.org.

Disclosure: The authors report no conflicts of interest.

Received March 20, 2007. Accepted in final form August 14, 2007.




This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
F. Agosta, K. A. Vossel, B. L. Miller, R. Migliaccio, S. J. Bonasera, M. Filippi, A. L. Boxer, A. Karydas, K. L. Possin, and M. L. Gorno-Tempini
Apolipoprotein E {varepsilon}4 is associated with disease-specific effects on brain atrophy in Alzheimer's disease and frontotemporal dementia
PNAS, February 10, 2009; 106(6): 2018 - 2022.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by AAN Enterprises, Inc.